Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-17-001941)

Filing Details

Accession Number:: 0000899243-17-001941
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-01-25 16:06:13
Reporting Period:: 2017-01-23

Filing Date:: 2017-01-25
Accepted Time:: 2017-01-25 16:06:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1114220	Keryx Biopharmaceuticals Inc	KERX	Pharmaceutical Preparations (2834)	134087132

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1640447	F. John Neylan	C/O Keryx Biopharmaceuticals, Inc. One Marina Park Drive, 12Th Floor Boston MA 02210	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-01-23	1,428	$5.39	90,128	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Sale of a total of 1,428 shares of common stock was made in order to satisfy Dr. Neylan's income tax withholding obligation upon the vesting of 3,750 shares of restricted stock on January 22, 2017. Dr. Neylan had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
Includes 72,500 shares of restricted stock.